We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of SCLN yet.

SCLN Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q4 2017, worth a combined $0 — down 100% from $394M a quarter earlier.

Sellers outnumbered buyers: 128 funds closed out of SCLN and 0 opened new positions — a net loss of 128 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $82.1M sold.

  • 0 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q4 2017, down from 129 in Q3 2017.
  • Funds reported $0 of Sciclone Pharmaceuticals Inc stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Sciclone Pharmaceuticals Inc positions in Q4 2017 and 128 closed out, a net change of -128 holders.
  • The largest Sciclone Pharmaceuticals Inc seller in Q4 2017 was BlackRock, an estimated $82.1M sold.

Based on aggregated 13F filings for Q4 2017.